JoelMKremerMDMACR, FACP
Rheumatology • Albany, NYRheumatoid Arthritis & Related
Pfaff Family Professor of Medicine, Albany Medical College,Director of Research, The Center for Rheumatology
Dr. Kremer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4 Tower Pl
8TH floor
Albany, NY 12203Phone+1 518-489-4471Fax+1 518-489-4506
Education & Training
Albany Medical CenterFellowship, Rheumatology, 1977 - 1979- Albany Medical CenterResidency, Internal Medicine, 1974 - 1977
Lewis Katz School of Medicine at Temple UniversityClass of 1974
Certifications & Licensure
NY State Medical License 1975 - 2027- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Alpha Omega Alpha
- Engalitcheff Award of the Arthritis Foundation
- Join now to see all
Clinical Trials
- A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis Start of enrollment: 2005 Dec 01
- The CORRONA Treat to Target Trial: Outcomes and Feasibility in a US Population Start of enrollment: 2011 Jul 01
- An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
- Join now to see all
Publications & Presentations
PubMed
- 75 citationsPatient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BE...Josef S Smolen, Joel M. Kremer, Carol L. Gaich, Amy M. DeLozier, Douglas E Schlichting
Annals of the Rheumatic Diseases. 2017-04-01 - 126 citationsA comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRON...Jeff Greenberg, George W. Reed, Dennis Decktor, Leslie R. Harrold, Daniel E. Furst
Annals of the Rheumatic Diseases. 2012-07-01 - 102 citationsLongterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of ExposureMark C. Genovese, Andrea Rubbert-Roth, Josef S Smolen, Joel M. Kremer, Majed Khraishi
The Journal of Rheumatology. 2013-06-01
Other
- Hepatotoxicity associated with chronic oral methotrexate for nonmalignant diseaseKremer JM
http://www.uptodate.com/contents/hepatotoxicity-associated-with-chronic-oral-methotrexate-for-nonmal
UpToDate, Wolters Kluwer Health - 2013-04-12 - Major side effects of low-dose methotrexateKremer JM
http://www.uptodate.com/contents/major-side-effects-of-low-dose-methotrexate
UpToDate, Wolters Kluwer Health - 2012-12-18 - Use of methotrexate in the treatment of rheumatoid arthritisKremer JM
http://www.uptodate.com/contents/use-of-methotrexate-in-the-treatment-of-rheumatoid-arthritis
UpToDate, Wolters Kluwer Health - 2012-05-04
Authored Content
- In Memoriam: Remembering William R. Palmer, MDAugust 2021
Press Mentions
- In Memoriam: Remembering William R. Palmer, MDAugust 24th, 2021
Extensive Assessment Critical to Dispel 'Ambiguity' Mimics in Juvenile DermatomyositisAugust 6th, 2021
Disease Activity and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis and Sjögren’s Syndrome Enrolled in a Large Observational US RegistryMay 24th, 2020- Join now to see all
Professional Memberships
- Fellow
- Master Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
